Angioedema by MDMA mediated by bradykinin. Role of icatibant acetate

Med Clin (Barc). 2021 Jan 22;156(2):99-100. doi: 10.1016/j.medcli.2019.10.020. Epub 2020 Feb 24.

[Article in English, Spanish]

Authors

Francesc Del Baño¹, August Supervía², Fernando Escolano³

Affiliations

¹ Servicio de Urgencias, Hospital del Mar, Barcelona, España.
² Servicio de Urgencias, Hospital del Mar, Barcelona, España; Unitat Funcional de Toxicología, Hospital del Mar, Barcelona, España. Electronic address: Asupervia@psmar.cat.
³ Servicio de Anestesiología y Reanimación, Hospital del Mar, Barcelona, España.

PMID: 32107042
DOI: 10.1016/j.medcli.2019.10.020

No abstract available

Publication types

Letter

MeSH terms

Angioedema* / chemically induced
Angioedemas, Hereditary*
Angiotensin-Converting Enzyme Inhibitors
Bradykinin / analogs & derivatives
Humans
N-Methyl-3,4-methylenedioxyamphetamine* / adverse effects

Substances

Angiotensin-Converting Enzyme Inhibitors
icatibant
N-Methyl-3,4-methylenedioxyamphetamine
Bradykinin